| PERIOD ENDING | 7-Nov-09 | 15-Aug-09 | 23-May-09 | 31-Jan-09 | | Total Revenue | 17,669,000 | 17,735,000 | 22,799,000 | 17,260,000 | | Cost of Revenue | 13,666,000 | 13,650,000 | 17,267,000 | 13,088,000 | | | Gross Profit | 4,003,000 | 4,085,000 | 5,532,000 | 4,172,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,292,000 | 3,238,000 | 4,235,000 | 3,165,000 | | Non Recurring | 1,113,000 |
-
|
-
|
-
| | Others | 356,000 | 348,000 | 453,000 | 348,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (758,000) | 499,000 | 844,000 | 659,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (758,000) | 499,000 | 844,000 | 659,000 | | Interest Expense | 105,000 | 115,000 | 163,000 | 115,000 | | Income Before Tax | (863,000) | 384,000 | 681,000 | 544,000 | | Income Tax Expense | 13,000 | 133,000 | 250,000 | 195,000 | | Minority Interest | 9,000 | (4,000) | 4,000 |
-
| | | | Net Income From Continuing Ops | (867,000) | 247,000 | 435,000 | 349,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (867,000) | 247,000 | 435,000 | 349,000 | | Preferred Stock And Other Adjustments | (8,000) | 8,000 |
-
|
-
| | | Net Income Applicable To Common Shares | ($875,000) | $255,000 | $435,000 | $349,000 |
|
0.02% Nasdaq 0.00%
Income Statement
